Acumen Pharmaceuticals, Inc. (NASDAQ: ABOS), a clinical-stage biopharmaceutical company developing a novel therapeutic that targets soluble amyloid beta oligomers (AβOs) for the treatment of Alzheimer ...
Earlier this year, the tiny rocket company that wants to grow up to be SpaceX someday told NASA that, if it's agreeable, ...
WEST CHESTER, Pa., March 26, 2025 (GLOBE NEWSWIRE) -- Verrica Pharmaceuticals Inc. ("Verrica” or the "Company”) (Nasdaq: VRCA ...
Tuesday’s 10 Worst Performers. In this article, we are going to take a look at where Recursion Pharmaceuticals Inc. (NASDAQ:RXRX) stands against other Tuesday’s worst performers. Wall Street finished ...
A dance showcase titled "Her Story; Her Comeback" will take place at the Brockton VFW on March 30. Tickets are available.
We recently compiled a list of the 12 Most Promising Biotech Stocks According to Wall Street Analysts. In this article, we are going to look at where Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) ...
Activist investor Keith Meister will join the board of gene-sequencing maker Illumina , and current board member Scott ...
Memphis basketball guard Jared Harris officially entered the transfer portal Tuesday, he told The Commercial Appeal.
Federal prosecutors have accused an Easton man of buying 14 guns for other people. Aaron Hypolite, 26, allegedly bought the ...
President Donald Trump’s tariffs on pharmaceuticals "to come at some point" as companies promise to build infrastructure in ...
X4 Pharmaceuticals, Inc. (XFOR) on Tuesday reported a loss of $39.8 million in its fourth quarter. On a per-share basis, the Boston-based company said it had a loss of ...
Corvus Pharmaceuticals Inc. (CRVS) on Tuesday reported a loss of $12.1 million in its fourth quarter. The Burlingame, California-based company ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results